[GSH] i was directly manipulated using either blockers of its synthesis, such as buthionine sulfoximine (BSO), or GSH cycle activators, such as sulforaphane (SFN) that enhances the expression of GSH synthetizing enzymes through the Nrf2 pathway activation
Acknowledgements This work was supported by grants from the Shenzhen Medical Academy of Research and Translation, Shenzhen, China (A2303031 to Shu Yang), the National Natural Science Foundation of China, China (82370876 to Shu Yang, 82170842 and 82371572 to Zhen Liang, 82171556 to Lin Kang, 82460150 to Xinyu Wang), National Science and Technology Major Project for the Prevention and Treatment of Cancer, Cardiovascular and Cerebrovascular, Respiratory and Metabolic Diseases, China (2024ZD0524800 and 2024ZD0524803), and Shenzhen Medical Research Fund, Shenzhen, China (C2406001)
Please see Table 10.8.A.CYTALUX (ovarian) CodesFY 2024 associated with this proposed rule for the complete list of codes that the applicant indicated were included in its cost analysis
Asymptomatic hyperuricemia: is it time to intervene